XML 57 R46.htm IDEA: XBRL DOCUMENT v3.25.4

Segment Reporting (Tables)

6 Months Ended

Dec. 31, 2025

Segment Reporting [Abstract]

Schedule of Information by Segments

The summary of key information by segments for the six months ended December 31, 2025 was as follows: 

		Cross-border freight solutions (U.S.)				Pharmaceutical distribution (China)				Holding				Total for the six months ended December 31, 2025
Revenue from external customers		$	8,110,140				3,780,654				—				11,890,794
Revenue from related parties		$	1,221,728				—				—				1,221,728
Cost of revenue		$	8,108,196				1,985,266				—				10,093,462
Gross profit		$	1,223,672				1,795,388				—				3,019,060
Selling expense		$	—				1,074,293				18,951				1,093,244
General and administrative expense		$	2,132,762				356,740				1,828,511				4,318,013
Depreciation & amortization		$	78,903				23,172				43,642				145,717
Income tax expense		$	—				81,039				—				81,039
Long-lived assets		$	2,297,112				418,551				373,566				3,089,229
Segment assets		$	6,421,111				3,725,331				14,153,766				24,300,208
Segment profit (loss)		$	(1,016,831	)			222,675				(2,146,741	)			(2,940,897	)

		Cross-border freight solutions (U.S.)				Pharmaceutical distribution (China)				Others				Total for the six months ended December 31, 2024
Revenue from external customers		$	6,702,063			$	218,086			$	–			$	6,920,149
Revenue from related parties		$	756,994			$	–			$	–			$	756,994
Cost of revenue		$	7,075,044			$	121,791			$	–			$	7,196,835
Gross profit		$	384,013			$	96,295			$	–			$	480,308
Depreciation & amortization		$	86,685			$	447			$	–			$	87,132
Income tax provision		$	89,581			$	–			$	–			$	89,581
Capital expenditure		$	181,963			$	74,351			$	–			$	256,314
Long-lived assets		$	4,582,950			$	816,826			$	–			$	5,399,776
Segment assets		$	7,092,574			$	1,949,879			$	794,673			$	9,837,126
Segment loss		$	(2,129,585	)		$	(334,567	)		$	(818,075	)		$	(3,282,227	)

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration